Hypertension Clinical Trial
Official title:
Influence of Different Doses of Coffee in the Blood Pressure Response Post-exercise
Introduction: reduction of blood pressure after physical exercise is called post exercise hypotension (PEH). However, previous studies demonstrate that ingestion of caffeine equivalent to three tea-cup of coffee abolishes this phenomenon. Objective: evaluate the influence of different doses of coffee in PEH. Methods: eleven hypertensive performed four experimental sessions of aerobic exercise in cycle ergometer (40 minutes of duration, intensity between 60% and 80% of maximum heart rate) succeeds for the ingestion of one (CAF-1), two (CAF-2), three (CAF-3) doses of caffeinated coffee (144 mg/dose), or three doses of decaffeinated coffee (DESC). Blood pressure was measured in rest and during 120 minutes of recovery post exercise, each 10 minutes.
Volunteers: participated 12 volunteers diagnosed as hypertensive, both gender (three men),
40 to 55 years old, overweight and practitioners of aerobic exercise (walk) at least three
months. They were treated with anti-hypertensive medication of class beta-adrenergic
receptor blockers, thiazides and enzyme convertor of angiotensin inhibitors, and showing
systolic and diastolic pressoric values controlled and habituated to coffee consumption.
Would be excluded from the study volunteers who presented migraine or other withdrawal
symptoms due to a washout to be carried out for coffee and other caffeinated foods. The
volunteers participated of this study for average one month. This study was previously
approved by Ethic Committee in Search with Humans at Hospital Lauro Wanderley, at Federal
University of Paraiba, under protocol 21/2011. All volunteers was previously clarified about
the experimental procedures, and they signed the written informed consent according
resolution 466/12 at Health National Council (Brazil).
Design of Study: the study was experimental, randomized and double-blind. Before the
experimental sessions the volunteers were instructed to avoid caffeinated foods during 48
hours. They performed four experimental sessions with the practice of aerobic exercise,
succeed for the ingestion of caffeinated or decaffeinated coffee, according to following
protocols: 1) one dose of 150 ml of coffee (144 mg of caffeine) ingested 10 minutes
post-exercise (CAF-1); 2- two doses of 150 ml of coffee (2x144 mg of caffeine) ingested 10
and 20 minutes post-exercise (CAF-2); three doses of 150ml of coffee (3x 144 mg of caffeine)
ingested 10, 20 and 30 minutes post-exercise (CAF-3); 4- three doses of 150 ml of
decaffeinated coffee (108 mg of caffeine) ingested 10, 20 and 30 minutes post-exercise
(DESC). The order of realization experimental sessions was determined randomly through the
site www.randomizer.org. They remained seated during 120 minutes after exercise. Blood
pressure was evaluated in rest, and during 120 minutes of post-exercise recovery, each 10
minutes.
Preparation and Ingestion of coffee: was utilized one caffeinated and decaffeinated coffee
(São Braz, Cabedelo, Brazil) with one same serial number. Caffeinated and decaffeinated
coffee had 1,2% and 0,3% of caffeine, respectively, in your composition. The method adopted
to the preparation of caffeinated or decaffeinated coffee was previously utilized for
Nóbrega et al. (15). Were prepared with addition of 40g coffee powder to each 500 ml of
heated water during five minutes, limited by beginning of boil. Thus, the volume of 500 ml
of coffee had one concentration of 480 mg of caffeine. Considering each tea-cup ingested had
one volume of 150 ml, so one, two and three tea-cups with coffee had respectively 144 mg,
288 mg and 432 mg of caffeine. Three tea-cups of decaffeinated coffee were 108 mg of
caffeine. The doses of caffeinated or decaffeinated coffee were sweetened with sugar
(Alegre, Mamanguape, Brazil). The coffee was strained with filters paper (Mellita®, Minden,
Alemanha). To ensure the accuracy of volume intake by volunteers at all time was utilized
one dosing tea-cup previously calibrated to volume of one tea-cup (150 ml). The intake
coffee was performed on first 30 minutes of period recovery, each 10 minutes. During moment
of ingestion, volunteers stay seated and was stipulated a deadline of five minutes to intake
the coffee.
Protocol of Physical Exercise: volunteers performed four experimental sessions with aerobic
exercise on a stationary bicycle (Perform V3, Movement®, Pompeia, Sao Paulo), lasting 40
minutes, intensity between 60 and 80% of maximum heart rate (MHR). To estimate of MHR was
utilized the equation proposed by Bruce et al. (16). To the prescription of target zone for
exercise was adopted the protocol proposed by Karvonen et al. (17). The heart rate of rest
and during the exercise was evaluated utilizing by cardiofrequencymeter (RS800CX, Polar
Electro® Oy, Kempele, Finland)
Measures of Blood Pressure: after the volunteers arrived on laboratory, they were oriented
to stay in rest seated during 10 minutes to measures of blood pressure on end of this
period. Others measures were realized during the 120 minutes of post-exercise recovery, each
10minutes. The first 30 minutes of post-exercise recovery the measures were always performed
one minute before coffee administration. The blood pressure was measured by auscultatory
method, following the protocol proposed by VI Brazilian Guidelines of Arterial Hypertension
(18). For this, was utilized one sphygmomanometer (Missouri, Embu, Brasil), previously
calibrated against one mercury column and one stethoscope (Missouri, Embu, Brasil).
Statistical Analysis: all the data are presented as mean±standard-error of mean. All
variables were tested for normal distribution using Shapiro-Wilk and Levene tests. For the
comparisons of age, body mass index, heart rate of rest, systolic and diastolic blood
pressure of rest between the experimental sessions was utilized one-way ANOVA. For the
comparisons of systolic and diastolic post-exercise between the experimental sessions of
study was realized two-way ANOVA plus Bonferroni test post hoc. P value small than 0,05 was
considered statically significant.
;
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator)
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |